16-33% of melanoma patients are helped by new FDA
Post# of 72440
https://www.bostonglobe.com/business/2015/10/...story.html
I certainly hope that Kevetrin has a better track record than that. But, this indicates that something that is not effective for the vast majority of patients can still be approved.
Now I wonder: what if they used a combo treatment of this virus PLUS Kevetrin? Might that not be much more effective -- mobilize the immune system, AND the p53 gene?